Celularity Inc. Depreciation
Celularity Inc. (CELU) reported Depreciation of $5.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-04-30
- Celularity Inc. depreciation for the quarter ending 2025-12-31 was $1.43M, a 4.87% decline year-over-year.
- Celularity Inc. depreciation for the quarter ending 2025-09-30 was $1.45M, a 4.67% decline year-over-year.
- Celularity Inc. depreciation for the quarter ending 2025-06-30 was $1.46M, a 5.06% decline year-over-year.
- Celularity Inc. depreciation for the quarter ending 2025-03-31 was $1.47M, a 8.94% decline year-over-year.
- Celularity Inc. depreciation for fiscal 2025 was $5.80M, a 5.93% decline from fiscal 2024.
- Celularity Inc. depreciation for fiscal 2024 was $6.17M, a 13.49% decline from fiscal 2023.
- Celularity Inc. depreciation for fiscal 2023 was $7.13M, a 1.55% decline from fiscal 2022.
- Celularity Inc. depreciation for fiscal 2022 was $7.24M, a 9.33% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $2.88M derived: sum of 2 quarters · filed 2026-04-30 | $4.34M derived: sum of 3 quarters · filed 2026-04-30 | $5.80M 10-K · filed 2026-04-30 |
| 2025-09-30 | $1.45M 10-Q · filed 2025-11-14 | $2.91M derived: sum of 2 quarters · filed 2025-11-14 | $4.38M 10-Q · filed 2025-11-14 | $5.88M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-06-30 | $1.46M 10-Q · filed 2025-08-29 | $2.93M 10-Q · filed 2025-08-29 | $4.43M derived: sum of 3 quarters · filed 2026-04-30 | $5.95M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-03-31 | $1.47M 10-Q · filed 2025-08-29 | $2.97M derived: sum of 2 quarters · filed 2026-04-30 | $4.49M derived: sum of 3 quarters · filed 2026-04-30 | $6.03M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $3.02M derived: sum of 2 quarters · filed 2026-04-30 | $4.56M derived: sum of 3 quarters · filed 2026-04-30 | $6.17M 10-K · filed 2026-04-30 |
| 2024-09-30 | $1.52M 10-Q · filed 2025-11-14 | $3.06M derived: sum of 2 quarters · filed 2025-11-14 | $4.67M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.54M 10-Q · filed 2025-08-29 | $3.15M 10-Q · filed 2025-08-29 | ||
| 2024-03-31 | $1.61M 10-Q · filed 2025-08-29 | |||
| 2023-12-31 | $7.13M 10-K · filed 2025-05-08 | |||
| 2022-12-31 | $7.24M 10-K · filed 2024-07-30 | |||
| 2022-03-31 | $1.74M 10-Q · filed 2022-05-16 | $3.80M derived: sum of 2 quarters · filed 2023-03-31 | $5.59M derived: sum of 3 quarters · filed 2023-03-31 | |
| 2021-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.85M derived: sum of 2 quarters · filed 2023-03-31 | $6.63M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.79M 10-Q · filed 2021-11-12 | $4.57M 10-Q · filed 2021-11-12 | ||
| 2021-03-31 | $1.40M 10-Q · filed 2022-05-16 | $2.68M derived: sum of 2 quarters · filed 2022-05-16 | $4.19M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.79M derived: sum of 2 quarters · filed 2022-03-31 | $4.78M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.51M 10-Q · filed 2021-11-12 | $3.50M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |